Aventis obtains United States patent.(Useful for treating retroviruses like AIDS)(Brief Article)

From: BIOTECH Patent News | Date: September 1, 2001 | Copyright information

Aventis Pasteur, Ltd. (Canada) has patented an immunogenic retrovirus-like particle which is non-infectious and non-replicating and which is useful as a candidate vaccine component against retroviral infections, including AIDS and ATLL, is produced...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

New data show that GlaxoSmithKline's Rotarix[R] could be given with other routine infant vaccines.(Items of Interest)
Pediatric Nursing ; GlaxoSmithKline (2007) recently announced new study results that indicate that Rotarix[R], an oral candidate vaccine for infants to prevent rotavirus gastroenteritis, could be co-administered with routine infant vaccines recommended in the U.S. at the 2 and 4-month old immunization visits, if
New data show that GSK's Rotarix could be given with other routine infant vaccines in the U.S.(Industry News)(Conference news)
Pharmaceutical Processing ; GlaxoSmithKline has released new study results that indicate that Rotarix[TM], an oral candidate vaccine for infants to prevent rotavirus gastroenteritis, could be co-administered with routine infant vaccines recommended in the U.S. at the two and four month old immunization visits, if approved by
Cervarix for protection against cervical cancer.(Pulse: The heartbeat of the marketplace)
CME: Your SA Journal of CPD ; GlaxoSmithKline's (GSK's) cervical cancer candidate vaccine, Cervarix, demonstrated 100% efficacy in preventing precancerous lesions due to cancer-causing human papillomavirus types 16 and 18 for up to 5.5 years. This efficacy was demonstrated in an extended follow-up trial conducted by GSK, and is
Fighting malaria; Vaccines.(GlaxoSmithKline Biologicals develop malaria vaccine, Mosquirix or RTS,S/AS02A )
The Economist (US) ; Biting back A new vaccine shows promising results MALARIA kills one child every 30 seconds and is the leading cause of death in young children in Africa. The World Health Organisation estimates that 300m people catch the disease every year, killing 1m people and directly contributing to the deaths
Research successful for malaria vaccine
China Daily ; SHANGHAI: PATH Malaria Vaccine Initiative (MVI), a US-based non- profit organization, reached an agreement with Shanghai Wanxing Bio- Pharmaceuticals yesterday, in a bid to support the drug producer's development of a paediatric vaccine against Plasmodium (P.) falciparum, the most deadly strain of
New vaccine candidate for cervical cancer.(Pulse: The heartbeat of the marketplace)(Brief article)
CME: Your SA Journal of CPD ; GlaxoSmithKline (GSK) has submitted a Biologics License Application (BLA) for its cervical cancer candidate vaccine (Cervarix), to the US Food and Drug Administration (FDA). Cervarix is a human papillomavirus vaccine (AS04 adjuvant-adsorbed) that, if licensed, will be indicated for the prevention
MP welcomes report urging TB vaccination.(Business)
The Journal (Newcastle, England) ; Byline: By Jennifer Mackenzie Andrew George MP, Liberal Democrat shadow rural affairs secretary, welcomed a report published by Defra yesterday which highlights the importance of developing vaccines to combat the spread of bovine TB. Mr George, who has recently pressed ministers on the development
Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
U.S. Newswire ; To: BUSINESS EDITORS Contact: Media, Chris Bona, +1-847-948-2815, UK Press Office + 44 (0) 207 618 9191 (United Kingdom), Investors, Mary Kay Ladone, +1- 847-948-3371, or Clare Trachtman, +1-847-948-3085, all of Baxter International Inc. DEERFIELD, Ill., and LONDON, Aug. 16 /PRNewswire-FirstCall/
BAXTER GETS CONTRACT FROM U.K. NHS FOR H5N1 FLU VACCINE.
Worldwide Biotech ; Baxter International Inc. (NYSE:BAX) has announced that its European subsidiary has received a contract from the National Health Service (NHS) in the United Kingdom to produce a stockpile of two million doses of candidate H5N1 influenza vaccine based on an avian strain. Under the agreement, Baxter
UK orders Baxter vaccine: Nation hopes it will help against bird flu.
Chicago Tribune (Chicago, IL) ; ... Hungary, Italy, Slovenia and Slovakia. bjapsen@tribune.com Bloomberg news contributed to this report Copyright (c) 2006, Chicago Tribune Distributed by Knight Ridder/Tribune Business News. For information on republishing this content, contact us at (800 ...